5 (1 votes) Employees with epilepsy cost healthcare insurers and employers significantly more than those without the condition, according to findings from two studies presented here today at the American Academy of Neurology (AAN) Annual Meeting. "These findings suggest that the true cost of epilepsy to third-party payors may often be underestimated when looking only at costs directly related to epilepsy," said Susan Caleo,trx cables, Director of Health Economics and Neurology at Johnson & Johnson Pharmaceutical Services, Inc. (JJPSI),exercise straps. JJPSI sponsored the study in collaboration with Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals,cheapest trx suspension trainer, Inc. "In particular, the studies suggest that perhaps most overlooked...